首页> 外国专利> Acute toxicity of pharmacotoxicological studies and the treatment of human beings with mu___e_electronic warfare_iv divided by___lambda___acid.

Acute toxicity of pharmacotoxicological studies and the treatment of human beings with mu___e_electronic warfare_iv divided by___lambda___acid.

机译:药物毒理学研究和对人类的急性毒性用mu___e_electronic warfare_iv除以___lambda___acid来治疗。

摘要

The present invention relates to the fight against a virus-infected host cell in the pharmaceutical field by inhibiting_iv to capture a protein E The company is in CD4 protein.For these purposes, a drug according to the present invention is presented in which the polypeptide protein contains an oxidizing, oxidizing and/or oxidizing peptide, the purchaser. Complete production methods from the blood, as well as the potential for these medications and non-therapies and the application of these drugs.
机译:本发明涉及在药物领域中通过抑制iv捕获蛋白E来对抗病毒感染的宿主细胞。该公司属于CD4蛋白。出于这些目的,提出了根据本发明的药物,其中多肽蛋白含有氧化,氧化和/或氧化肽的购买者。血液的完整生产方法,以及这些药物和非疗法的潜力以及这些药物的应用。

著录项

  • 公开/公告号CY1112243T1

    专利类型

  • 公开/公告日2015-12-09

    原文格式PDF

  • 申请/专利号CY201211000035T

  • 发明设计人 KEHREL BEATE;

    申请日2012-01-11

  • 分类号A61P31/18;A61K35/14;A61K35/16;A61K38/36;A61K38/38;A61K38/57;

  • 国家 CY

  • 入库时间 2022-08-21 14:26:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号